NanoMosaic's technology is designed to support upstream and downstream process development, quality control, and release testing.

Disrupted hippocampal replay in an Alzheimer’s mouse model reveals how memory consolidation breaks down, offering clues for early diagnosis.

Engineered BiTE molecule draws T cells to eliminate FAP+ modulated smooth muscle cells, reducing plaque burden across mouse atherosclerosis models.

A new mouse study found that unrepaired DNA-protein crosslinks activate inflammatory signaling pathways that trigger early aging disorders.

AlphaGenome is a DNA sequence model that advances regulatory variant-effect prediction to understand genome function.

The partnership’s goal is to enable refined patient stratification, improved biomarker discovery, and data-driven therapeutic strategies.

Yeast-based protein expression systems will likely play an important role in vaccine production during future pandemics.

A new study published in Nature in the paper, “Developmental convergence and divergence in human stem cell models of autism,” provides new insights by demonstrating that while different mutations ...

Nader Z. Pourhassan, PhD, the former CEO of CytoDyn, was sentenced yesterday to 30 months in prison, more than a year after he was convicted on charges that included four counts of securities fraud, ...

The partnership is supported by the Michael J. Fox Foundation, which seeks to better understand aSyn protein's role in Parkinson's disease.

Knowing which lysosomal proteins are enriched in which brain cell types will help better understand contribution to neurological disorders.

Insilico Medicine has launched Science MMAI Gym, a domain-specific training infrastructure designed to transform LLMs into their best shape for drug discovery and development.